永太科技：关于全资子公司获得药品注册证书的公告

Group 1 - The core announcement is that Yongtai Technology's wholly-owned subsidiary, Binhai Meikang Pharmaceutical Co., Ltd., has received the drug registration certificate for Lidocaine and Prilocaine Cream from the National Medical Products Administration [2] Group 2 - The approval signifies a regulatory milestone for the company, potentially enhancing its product portfolio in the pharmaceutical sector [2] - This development may lead to increased market opportunities and revenue growth for Yongtai Technology in the future [2]